ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2285

Higher Than Expected Rates of Adverse Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus from Three Tertiary Care Centers

Ashley Blaske1, Amanda Eudy 2, Katie Kirchoff 3, Jim Oates 4, Megan Clowse 2 and April Barnado 1, 1Vanderbilt University Medical Center, Nashville, TN, 2Duke University, Durham, 3Medical University of South Carolina, Charleston, SC, 4Division of Rheumatology & Immunology/Medical University of South Carolina, Charleston, SC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pregnancy and Electronic Health Record, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Prospective cohort studies of pregnancies managed by experts demonstrate that up to 30% of systemic lupus erythematosus (SLE) pregnancies result in preterm birth. We assembled a real-world, multi-center, electronic health record (EHR)-based cohort of SLE births from three tertiary care centers in the Southeastern United States to assess the impact of race on adverse pregnancy outcomes.

Methods: Centers 1 and 2 selected subjects with at least 1 count of the SLE ICD-9 (710.0) or ICD-10 codes (M32.1*, M32.8, M32.9) and at least 1 ICD-9 or ICD-10 code for pregnancy-related diagnoses from 2013-2018. These subjects were reviewed by a rheumatologist to determine if the subject had SLE. Pregnancy outcomes were extracted as discrete variables through the EHR. Center 3 subjects had at least 4 counts of the SLE ICD-9 code or ICD-10 codes and at least 1 ICD-9 or ICD-10 code for pregnancy-related diagnoses. A subject was defined as a case if diagnosed with SLE by a rheumatologist, nephrologist, or dermatologist. Pregnancy outcomes were assessed through chart review for deliveries from 1993-2017.  Only pregnancies that delivered at the academic center, had available pregnancy outcomes, and occurred after SLE diagnosis were included.  Age-adjusted logistic regression models measured the association of maternal race with preterm birth and preeclampsia.

Results: Across the 3 centers, there were 131 women with SLE with 146 pregnancies.  The mean age at delivery of 29 years was similar across the 3 centers (Table 1).  The demographics were different between centers with more Black women at Center 1 (71%) and 2 (66%) compared to Center 3 (38%); there were very few Hispanic women.  Overall, the rate of preterm birth was 42% with a mean gestational age of 35.7 weeks, which was similar in each center.  More than half (54%) of all pregnancies were delivered surgically.  Preeclampsia complicated 24% of all pregnancies, with the rate of preeclampsia twice as high in Center 1 (38%) compared to Centers 2 and 3 (17%).   The large majority of preeclamptic deliveries occurred preterm (79%). When adjusting for maternal age, Black race was not significantly associated with preterm birth (OR = 1.28, 95% CI 0.62 – 2.62, p = 0.5) or preeclampsia (OR = 1.66, 95% CI 0.65 – 4.26, p = 0.3).

Conclusion: We observed higher than previously reported rates of preeclampsia, preterm birth, and Caesarean section at all 3 centers. Only slightly more than half of the deliveries were term and without preeclampsia. In the general population, preeclampsia is most common at term, whereas in this cohort 79% of preeclampsia occurred preterm. These findings likely reflect the severity of disease seen at large tertiary care referral centers in the Southeastern US. While the proportion of pregnancies to Black women was higher in this cohort than others, multivariate analysis demonstrated that race was not associated with adverse outcomes.  We hypothesize that these findings reflect referral bias of the sickest SLE patients of all races to deliver at a tertiary care center. Our findings demonstrate that even at specialized, tertiary care centers, there is an unmet need for management guidelines that reduce adverse pregnancy outcomes in SLE.


SLEpreg abstract 0601 table 1


Disclosure: A. Blaske, None; A. Eudy, GSK, 2; K. Kirchoff, None; J. Oates, None; M. Clowse, GSK, 2, UCB, 5; A. Barnado, NIH/NIAMS 5K08AR072757-02, 2.

To cite this abstract in AMA style:

Blaske A, Eudy A, Kirchoff K, Oates J, Clowse M, Barnado A. Higher Than Expected Rates of Adverse Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus from Three Tertiary Care Centers [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/higher-than-expected-rates-of-adverse-pregnancy-outcomes-in-patients-with-systemic-lupus-erythematosus-from-three-tertiary-care-centers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-than-expected-rates-of-adverse-pregnancy-outcomes-in-patients-with-systemic-lupus-erythematosus-from-three-tertiary-care-centers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology